. "RIV/00216208:11120/14:43908605!RIV15-MSM-11120___" . "3" . "[541398C455BC]" . "Polycystic ovary syndrome is the most common cause of ovarian dysfunction and anovulatory infertility in women. The insulin resistance occurs very frequently as a part of PCOS. This paper reviews the literature documenting the effectiveness of insulin sensitizer myo-inositol in the treatment of ovarian dysfunction, symptoms of hyperandrogenism and wide complex of symptoms of metabolic syndrome. Six randomized controlled trials provides evidence of a positive effect of myo-inositol to normalize ovarian function, improve laboratory and clinical manifestations of hyperandrogenism and insulin resistance. The myo-inositol treatment has been demonstrated as a safe method of PCOS management."@en . . "Myo-inositol in the treatment of polycystic ovary syndrome"@en . "CZ - \u010Cesk\u00E1 republika" . "Myoinositol v terapii syndromu polycystick\u00FDch ovari\u00ED"@cs . "Myo-inositol in the treatment of polycystic ovary syndrome"@en . "31266" . "\u010Cesk\u00E1 gynekologie" . . "metformin; myoinositol; insulin sensitizers; insulin resistance syndrome; polycystic ovary syndrome"@en . "Myoinositol v terapii syndromu polycystick\u00FDch ovari\u00ED" . "11120" . . "PCOS je nej\u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinou ovari\u00E1ln\u00ED dysfunkce a anovula\u010Dn\u00ED neplodnosti \u017Een. V r\u00E1mci PCOS se velmi \u010Dasto vyskytuje inzulinorezistence. \u010Cl\u00E1nek p\u0159in\u00E1\u0161\u00ED p\u0159ehled literatury dokl\u00E1daj\u00EDc\u00ED efektivitu inzulinov\u00E9ho senzitiz\u00E9ru myoinositolu v l\u00E9\u010Db\u011B ovari\u00E1ln\u00ED dysfunkce, projev\u016F hyperandrogenismu a \u0161irok\u00E9ho komplexu symptom\u016F metabolick\u00E9ho syndromu. \u0160est randomizovan\u00FDch kontrolovan\u00FDch studi\u00ED p\u0159edkl\u00E1d\u00E1 d\u016Fkazy o pozitivn\u00EDm \u00FA\u010Dinku myoinositolu na normalizaci ovari\u00E1ln\u00EDch funkc\u00ED, zlep\u0161en\u00ED laboratorn\u00EDch i klinick\u00FDch projev\u016F hyperandrogenismu a inzulinorezistence. Terapie myoinositolem byla ov\u011B\u0159ena jako velmi bezpe\u010Dn\u00E1 metoda l\u00E9\u010Dby PCOS." . "1"^^ . . "RIV/00216208:11120/14:43908605" . . . . "I" . . "1"^^ . . . "5"^^ . "79" . . . "Myoinositol v terapii syndromu polycystick\u00FDch ovari\u00ED"@cs . "K\u0159epelka, Petr" . "1210-7832" . . . . "PCOS je nej\u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinou ovari\u00E1ln\u00ED dysfunkce a anovula\u010Dn\u00ED neplodnosti \u017Een. V r\u00E1mci PCOS se velmi \u010Dasto vyskytuje inzulinorezistence. \u010Cl\u00E1nek p\u0159in\u00E1\u0161\u00ED p\u0159ehled literatury dokl\u00E1daj\u00EDc\u00ED efektivitu inzulinov\u00E9ho senzitiz\u00E9ru myoinositolu v l\u00E9\u010Db\u011B ovari\u00E1ln\u00ED dysfunkce, projev\u016F hyperandrogenismu a \u0161irok\u00E9ho komplexu symptom\u016F metabolick\u00E9ho syndromu. \u0160est randomizovan\u00FDch kontrolovan\u00FDch studi\u00ED p\u0159edkl\u00E1d\u00E1 d\u016Fkazy o pozitivn\u00EDm \u00FA\u010Dinku myoinositolu na normalizaci ovari\u00E1ln\u00EDch funkc\u00ED, zlep\u0161en\u00ED laboratorn\u00EDch i klinick\u00FDch projev\u016F hyperandrogenismu a inzulinorezistence. Terapie myoinositolem byla ov\u011B\u0159ena jako velmi bezpe\u010Dn\u00E1 metoda l\u00E9\u010Dby PCOS."@cs . "Myoinositol v terapii syndromu polycystick\u00FDch ovari\u00ED" .